Latest Addiction Medicine News

Irene Chernova, MD, PhD, instructor of medicine (nephrology) has been selected as the recipient of the 2023 Iva Dostanic, MD, PhD, Physician-Scientist Trainee Award.

Ryan McNeil, PhD, associate professor of medicine (general medicine), comments on the challenge of tracking street drugs.

Ryan McNeil, PhD, associate professor of medicine (general medicine), weighs in on the price of overdose antidote Narcan.

A new study across 28 emergency departments (EDs) with a high prevalence of fentanyl use has found that the incidence of a severe withdrawal reaction after use of buprenorphine is rare—less than one percent, a result that pleasantly surprised the researchers.

Kimberly Sue, MD, PhD, assistant professor of medicine (general internal medicine), notes concerns about the price of an over-the-counter medicine that can help reverse opioid overdoses.

In 2022, adolescents with a substance use disorder in Connecticut utilized emergency services at twice the rate of adults (18% versus 9%) with comparatively low engagement in lifesaving substance use disorder treatments (1%). The Yale Adolescent Addiction Medicine Consult Service and Adolescent Addiction Prevention Clinic are bringing critically needed services to teens and their families in hospital-based, outpatient, and school-based settings .

The U.S. Drug Enforcement Administration issued a warning nationwide for the drug known as xylazine.

Overdose deaths are dropping in Connecticut, according to early data from the state’s department of public health. The initial statistics show that confirmed overdose deaths fell 6% in 2022 compared to 2021, but leaders are still waiting on the final results.

David Fiellin, MD, professor of medicine (general medicine), talks about the lifting of buprenorphine restrictions.